Farther Finance Advisors’s Gossamer Bio GOSS Stock Holding History

Farther Finance Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.6K	Buy	641 +589	+1,133%	+$7.64K	﹤0.01%	4787
2026 Q2	$688	Buy	52 +6	+13%	+$134	﹤0.01%	5469
2026 Q1	$1.34K	Buy	46 +40	+667%	+$5.03K	﹤0.01%	5026
2025 Q4	$1.44K	Buy	6 +5	+500%	+$1.14K	﹤0.01%	4805
2025 Q3	$184	Buy	+1	New	+$176	﹤0.01%	4735
2025 Q1	–	Sell	-5	Closed	-$362	–	4319
2024 Q4	$362	Buy	+5	New	+$343	﹤0.01%	3511

Other funds holding GOSS

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

Farther Finance Advisors's GOSS Position: Q3 2026 in Review

Farther Finance Advisors increased its Gossamer Bio (GOSS) stake by 1,133% in Q3 2026, buying an estimated $7.64K and bringing the position to 641 shares worth $7.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4787.

Farther Finance Advisors first reported a position in GOSS in Q4 2024 and has held it in 6 quarters since. 3 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

Farther Finance Advisors held 641 shares of Gossamer Bio worth $7.6K as of Q3 2026.
Farther Finance Advisors bought 589 Gossamer Bio shares in Q3 2026, an estimated $7.64K.
Gossamer Bio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4787 holding.
Farther Finance Advisors first reported a position in Gossamer Bio in Q4 2024 and has held it in 6 quarters since.
3 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.